Design, Synthesis, and Biological Activities of Novel Triazolothiadiazole Derivatives Linked with Amino Side Chain Containing Urea Group as DOT1L Inhibitors

doi:10.6023/cjoc201910037

Chinese Journal of Organic Chemistry ›› 2020, Vol. 40 ›› Issue (8): 2450-2459.DOI: 10.6023/cjoc201910037 Previous Articles Next Articles

连氨基脲链的三氮唑并噻二唑类DOT1L抑制剂的设计、合成及活性

刘娜^a, 郭思岐^b,c, 刘俊芳^a, 陈彦韬^b, 徐晓明^a, 张静^a, 康亚青^a, 罗成^b, 陈示洁^b, 陈华^a

a 河北大学化学与环境科学学院河北省化学生物学重点实验室河北保定 071002;
b 中国科学院上海药物研究所新药研究国家重点实验室上海 201203;
c 南昌大学药学院南昌 330006

收稿日期:2019-10-29 修回日期:2020-01-13 发布日期:2020-05-28
通讯作者: 陈示洁, 陈华 E-mail:shijiechen@simm.ac.cn;hua-todd@163.com
基金资助:
河北大学自然科学多学科交叉研究计划（No.DXK201903）资助项目.

Design, Synthesis, and Biological Activities of Novel Triazolothiadiazole Derivatives Linked with Amino Side Chain Containing Urea Group as DOT1L Inhibitors

Liu Na^a, Guo Siqi^b,c, Liu Junfang^a, Chen Yantao^b, Xu Xiaoming^a, Zhang Jing^a, Kang Yaqing^a, Luo Cheng^b, Chen Shijie^b, Chen Hua^a

a Key Laboratory of Chemical Biology of Hebei Province, College of Chemistry and Environmental Science, Hebei University, Baoding, Hebei 071002;
b State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 201203;
c School of Pharmacy, Nanchang University, Nanchang 330006

Received:2019-10-29 Revised:2020-01-13 Published:2020-05-28
Supported by:
Project supported by the Natural Science Interdisciplinary Research Program of Hebei University (No. DXK201903).

1. cjoc201910037辅助材料.pdf(4676KB)

Abstract

Based on the drug design method of combination of privileged fragments, a series of novel triazolothiadiazole derivatives linked with amino side chain containing urea group were designed as potential DOT1L (disruptor of telomeric silencing 1-like) inhibitors. The intermediate 13 with benzyl chloride on triazolothiadiazole structure was synthesized from aromatic acid through five steps. Under the condition of weak base (DIPEA), the nucleophilic substitution reaction between 13 and amino chain with urea group resulted in triazolothiadiazole derivatives linked with amino side chain containing urea group 15a~15k, while under the condition of strong base (NaH), the new dimeric structure analogues 22a~22d bearing with triazolothiadiazole-triazolothiadiazine were obtained by intermolecular reaction of two molecules of 13. The inhibitory activities of compounds 15 and 22 against DOT1L were tested. The results showed that the tested compounds exhibited moderate or weak DOT1L inhibitory activities at 50 μmol·L^-1. Among them, compounds 15k and 22a were the best ones with IC₅₀ values of 25.92 and 10.59 μmol·L^-1, respectively, lower than that of the positive control (E)-6-(2-(furan-2-yl)vinyl)-3-phenyl-[1,2, 4]triazolo[3,4-b] [1,3,4]thiadiazole (10). The results of docking experiments suggested that the bulky amino-urea side chain might be the main reason for the loss of the activities of the compounds, which sterically hindered the molecular from binding to the DOT1L enzyme.

Key words: DOT1L inhibitor, triazolothiadiazole, triazolothiadiazine, nucleophilic substitution

Cite this article

Liu Na, Guo Siqi, Liu Junfang, Chen Yantao, Xu Xiaoming, Zhang Jing, Kang Yaqing, Luo Cheng, Chen Shijie, Chen Hua. Design, Synthesis, and Biological Activities of Novel Triazolothiadiazole Derivatives Linked with Amino Side Chain Containing Urea Group as DOT1L Inhibitors[J]. Chinese Journal of Organic Chemistry, 2020, 40(8): 2450-2459.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Min, J. R.; Feng, Q.; Li, Z. Z.; Zhang, Y.; Xu, R. M. Cell 2003, 112, 711.
[2] Kim, W.; Choi, M.; Kim, J. E. Cell Cycle 2014, 13, 726.
[3] Bernt, K. M.; Zhu, N.; Sinha, A. U.; Vempati, S.; Faber, J.; Krivtsov, A. V.; Feng, Z.; Punt, N.; Daigle, A.; Bullinger, L.; Pollock, R. M.; Richon, V. M.; Kung, A. L.; Armstrong, S. A. Cancer Cell 2011, 20, 66.
[4] Lillico, R.; Lawrence, C. K. Lakowski, T. M. J. Proteome Res. 2018, 17, 2657.
[5] Anglin, J. L.; Song, Y. J. Med. Chem. 2013, 56, 8972.
[6] Zhou, S. H.; Sun, P. J.; Zhao, Y. Q.; Zhang, Y.; Yu, N. F. Acta Pharm. Sin. 2018, 53, 500(in Chinese). (周仕海, 孙朋举, 赵勇强, 张岩, 余聂芳, 药学学报, 2018, 53, 500.)
[7] Ümit Kaniskan, H.; Martini, M. L.; Jin, J. Chem. Rev. 2018, 118, 989.
[8] Basavapathruni, A.; Jin, L.; Daigle, S. R.; Majer, C. R.; Therkelsen, C. A.; Wigle, T. J.; Kuntz, K. W.; Chesworth, R.; Pollock, R. M.; Scott, M. P. Moyer, M. P.; Richon, V. M.; Copeland, R. A.; Olhava, E. J. Chem. Biol. Drug Des. 2012, 80, 971.
[9] Daigle, S. R.; Olhava, E. J.; Therkelsen, C. A.; Majer, C. R.; Sneeringer, C. J.; Song, J.; Johnston, L. D.; Scott, M. P.; Smith, J. J.; Xiao, Y.; Jin, L.; Kuntz, K. W.; Chesworth, R.; Moyer, M. P.; Bernt, K. M.; Tseng, J. C.; Kung, A. L.; Copeland, R. A.; Richon, V. M.; Pollock, R. M. Cancer Cell 2011, 20, 53.
[10] Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Savona, M.; Tibes, R.; Altman, J. K.; Jongen-Lavrencic, M.; Dohner, H.; Armstrong, S.; Pollock, R. M.; Waters, N. J.; Legler, M.; Thomson, B.; Daigle, S.; McDonald, A.; Campbell, C.; Olhava, E.; Hedrick, E. E.; Lowenberg, B.; Copeland, R. A.; Tallman, M. S. Blood 2014, 124, 387.
[11] Yao, Y.; Chen, P.; Diao, J.; Cheng, G.; Deng, L.; Anglin, J. L.; Prasad, B. V.; Song, Y. J. Am. Chem. Soc. 2011, 133, 16746.
[12] Anglin, J. L.; Deng, L.; Yao, Y.; Cai, G.; Liu, Z.; Jiang, H.; Cheng, G.; Chen, P.; Dong, S.; Song, Y. J. Med. Chem. 2012, 55, 8066.
[13] Yu, W.; Chory, E. J.; Wernimont, A. K.; Tempel, W.; Scopton, A.; Federation, A.; Marineau, J. J.; Qi, J.; Barsyte-Lovejoy, D.; Yi, J.; Marcellus, R.; Iacob, R. E.; Engen, J. R.; Griffin, C.; Aman, A.; Wienholds, E.; Li, F.; Pineda, J.; Estiu, G.; Shatseva, T.; Hajian, T.; Al-Awar, R.; Dick, J. E.; Vedadi, M.; Brown, P. J.; Arrowsmith, C. H.; Bradner, J. E.; Schapira, M. Nat. Commun. 2012, 3, 1288.
[14] Yu, W.; Smil, D.; Li, F.; Tempel, W.; Fedorov, O.; Nguyen, K. T.; Bolshan, Y.; Al-Awar, R.; Knapp, S.; Arrowsmith, C. H.; Vedadi, M.; Brown, P. J.; Schapira, M. Bioorg. Med. Chem. 2013, 21, 1787.
[15] Spurr, S. S.; Bayle, E. D.; Yu, W. Y.; Li, F. L.; Tempel, W.; Vedadi, M.; Schapira, M.; Fish, P. V. Bioorg. Med. Chem. Lett. 2016, 26, 4518.
[16] Chen, J.; Park, H. J. ACS Chem. Biol. 2019, 14, 873.
[17] Scheufler, C.; Möbitz, H.; Gaul, C.; Ragot, C.; Be, C.; Fernández, C.; Beyer, K. M.; Tiedt, R.; Stauffer, F. ACS Med. Chem. Lett. 2016, 7, 730.
[18] Chao, C.; Zhu, H.; Stauffer, F.; Caravatti, G.; Vollmer, S.; Machauer, R.; Holzer, P.; Möbitz, H.; Scheufler, C.; Klumpp, M.; Tiedt, R.; Beyer, K. S.; Calkins, K.; Guthy, D.; Kiffe, M.; Zhang, J.; Gaul, C. ACS Med. Chem. Lett. 2016, 7, 735.
[19] Möbitz, H.; Machauer, R.; Holzer, P.; Vaupel, A.; Stauffer, F.; Ragot, C.; Caravatti, G.; Scheufler, C.; Fernández, C.; Hommel, U.; Tiedt, R.; Beyer, K. S.; Chao, C.; Zhu, H.; Gaul, C. ACS Med. Chem. Lett. 2017, 8, 338.
[20] Chen, S. J.; Wang, Y. L.; Zhou, W.; Li, S. S.; Peng, J. L.; Shi, Z.; Hu, J. C.; Liu, Y. C.; Ding, H.; Lin, Y. Y.; Li, L. J.; Cheng, S. F.; Liu, J. Q.; Lu, T.; Jiang, H. L.; Liu, B.; Zheng, M. Y.; Luo, C. J. Med. Chem. 2014, 57, 9028.
[21] Chen, S.; Li, L.; Chen, Y.; Hu, J.; Liu, J.; Liu, Y. C.; Liu, R.; Zhang, Y.; Meng, F.; Zhu, K.; Lu, J.; Zheng, M.; Chen, K.; Zhang, J.; Jiang, H.; Yao, Z.; Luo, C. J. Chem. Inf. Model. 2016, 56, 527.
[22] Wang, Y. L.; Li, L. J.; Zhang, B. D.; Xing, J.; Chen, S. J.; Wan, W.; Song, Y. K.; Jiang, H.; Jiang, H. L.; Luo, C.; Zheng, M. Y. J. Med. Chem. 2017, 60, 2026.
[23] Song, Y. K.; Li, L. J.; Chen, Y. T.; Liu, J. Q.; Xiao, S. H.; Lian, F. L.; Zhang, N. X.; Ding, H.; Zhang, Y. Y.; Chen, K. X.; Jiang, H. L.; Zhang, C. H.; Liu, Y. C.; Chen, S. J.; Luo, C. Bioorg. Med. Chem. 2018, 26, 1751.
[24] Zhang, L.; Chen, Y. T.; Liu, N.; Li, L. J.; Xiao, S. H.; Li, X. L.; Chen, K. X.; Luo, C.; Chen, S. J.; Chen, H. Bioorg. Chem. 2018, 80, 649.
[25] Cui, P. L.; Li, X. L.; Zhu, M. Y.; Wang, B. H.; Liu, J.; Chen, H. Eur. J. Med. Chem. 2017, 127, 159.
[26] Maestro, Version 10.4, Schrödinger, LLC, New York, 2015.
[27] Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. J. Med. Chem. 2004, 47, 1739.
[28] Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. J. Med. Chem. 2006, 49, 6177.
[29] Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye, L. L.; Thomas Pollard, W.; Banks, J. L. J. Med. Chem. 2004, 47, 1750.
[30] Glide, Version 6.9, Schrödinger, LLC, New York, 2015.

连氨基脲链的三氮唑并噻二唑类DOT1L抑制剂的设计、合成及活性

Design, Synthesis, and Biological Activities of Novel Triazolothiadiazole Derivatives Linked with Amino Side Chain Containing Urea Group as DOT1L Inhibitors

PDF

Supporting Info.

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yong Zhang, Zhigao Tian, Lin Huang, Qiufei Hou, Honghong Fan, Wanqiang Wang. Application of α-Cyanohydrin Methanesulfonates for the Synthesis of α-Aminonitriles [J]. Chinese Journal of Organic Chemistry, 2024, 44(2): 561-572.
[2]	Zhiyou Huang, Ping Yang, Bo He, Wenxia Ou, Siyu Yuan. Design and Synthesis of Morpholine Sulfonamide Compound and Its Inhibition on Soybean Seed Germination [J]. Chinese Journal of Organic Chemistry, 2024, 44(1): 309-315.
[3]	Leigang Wang, Yixuan Zheng, Xi Zhou, Haifeng Wang, Qiongjiao Yan, Wei Wang, Fener Chen. Synthesis of α-Aryl Nitriles via Nucleophilic Substitution of α-Cyanohydrin Methanesulfonates with Malonates [J]. Chinese Journal of Organic Chemistry, 2023, 43(2): 668-678.
[4]	Yuan Zhu, Leyuan Chen, Wenbin Hou, Yiliang Li. Recent Progress in Nucleophilic Fluoride Mediated Fluorine-18 Labeling of Arenes and Heteroarenes [J]. Chinese Journal of Organic Chemistry, 2021, 41(5): 1774-1788.
[5]	Xinling Li, Huili Liu, Shunji Zhang. Direct Nucleophilic Substitution of Propargyl Alcohols with Enoxysilanes [J]. Chinese Journal of Organic Chemistry, 2021, 41(1): 407-411.
[6]	Li Ruoxin, Han Rui, Gao Jinming. Synthesis of Key Intermediate of Cyathane Diterpenes [J]. Chinese Journal of Organic Chemistry, 2020, 40(7): 2148-2152.
[7]	Zhang Shunji, Liu Huili. Sulfuric Acid Catalyzed Rapid Nucleophilic Substitution of Propargyl Alcohols [J]. Chinese Journal of Organic Chemistry, 2020, 40(5): 1257-1265.
[8]	Xu Xiaoming, Guo Siqi, Zhang Jing, Chen Yantao, Kang Yaqing, Liu Na, Liu Junfang, Luo Cheng, Chen Shijie, Chen Hua. Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities [J]. Chinese Journal of Organic Chemistry, 2020, 40(5): 1345-1354.
[9]	Han Man-Yi, Pan Hong, Yao Ziyun, Li Qi. n-Bu₄NBr Catalyzed Brook Rearrangement/Alkylation Reaction [J]. Chinese Journal of Organic Chemistry, 2020, 40(12): 4274-4283.
[10]	Zhang Chenglu, Li Chuanyin, Gu Yaodong, Sun Xiaona, Tang Jie, Wang Jing, Li Yizheng, Wang Huayu. Synthesis and Bioactivity Evaluation of Novel 1, 3, 5-Triazine-1H-pyrazole-triazol-ethiadiazole Derivatives [J]. Chin. J. Org. Chem., 2018, 38(5): 1223-1232.
[11]	Li Yingjun, Li Jiyang, Peng Lin, Gao Lixin, Jin Kun, Sheng Li, Zhang Nan, Wang Siyuan, Li Jia. Synthesis and Cell Division Cycle 25B Phosphatase and Protein Ty-rosine Phosphatase 1B Inhibitory Activity Evaluation of Novel 3,6-Disubstituted Triazolothiadiazole Derivatives [J]. Chin. J. Org. Chem., 2017, 37(2): 485-495.
[12]	Zhang Xiaoxiang, Lü Chang, Li Ping, Fu Bo, Yao Weiwei. Progress of the Research on the Lewis/Brønsted Acid-Catalyzed Nucleophilic Substitution of Propargyl Alcohols [J]. Chin. J. Org. Chem., 2016, 36(6): 1287-1298.
[13]	Sun Zhidong, Zhu Yunlong, Huang Haiyang, Song Xianrong, Xiao Qiang. Studies on the Total Synthesis of iso-L-Cystidine [J]. Chin. J. Org. Chem., 2016, 36(11): 2729-2734.
[14]	Zhang Xiaoxiang, Sun Xiaoping, Tan Jihuai, Fan Hui, Rao Weidong. Progress of Nucleophilic Substitution of Allylic Alcohols [J]. Chin. J. Org. Chem., 2015, 35(10): 2049-2058.
[15]	Ma Congming, Hou Kehui, Liu Zuliang, Yao Qizheng. A Convenient Preparation Method for 2-Amino-3,5-dinitro-6-chloropyridine and Its Derivatives [J]. Chin. J. Org. Chem., 2014, 34(3): 584-588.